JILL ANN BERK: Open Payments
NPI 1821415225 · NEWPORT, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 8 payments from 5 companies in 2025. Trend: 2023 $177 · 2024 $359 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $61 |
| ABBVIE INC. | 3 | $60 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: REXULTI, VRAYLAR, INGREZZA, FANAPT, CAPLYTA.
Industry payments across RI — which companies pay providers there.
